通冠胶囊对急性冠脉综合征患者超敏C反应蛋白水平的影响的论文.docVIP

　　通冠胶囊对急性冠脉综合征患者超敏C反应蛋白水平的影响的论文 【摘要】 　　【目的】观察通冠胶囊对急性冠脉综合征(acs)患者超敏c反应蛋白(hscrp)水平的影响。【方法】将acs患者54例随机分为治疗组26例和对照组28例。2组给予一致的冠心病标准治疗和并发症处理,对照组加用安慰剂,治疗组加用通冠胶囊,疗程均为1个月。比较2组患者治疗前后的症状量化评分,并分别在入院时、治疗第7天和1个月后观察患者hscrp水平的变化。【结果】治疗后2组acs患者症状量化评分有不同程度地改善(与治疗前比较,plt;005或plt;001),其中治疗组在改善患者胸闷痛程度、发作频率、持续时间和气短、疲乏、心悸等方面优于对照组(plt;005或plt;001)。治疗第7天和1个月后对照组患者的hscrp水平均无明显变化(与入院时比较,pgt;005),而治疗组患者的hscrp水平均下降(与入院时比较,plt;005),尤其在治疗1个月后下降更为明显(与治疗第7天比较,p lt;005)。治疗后2组比较,治疗组的hscrp水平下降程度均优于对照组(plt;005)。【结论】通冠胶囊可显著改善acs患者的症状,并能降低acs患者的hscrp水平。 【关键词】 通冠胶囊/治疗应用 急性冠脉综合征/中西医结合疗法 超敏c反应蛋白/血液 　　effect of tongmai capsules on highsensitivity creactive protein in acute coronary syndrome patients 　　ding banghan,chen jiana,zou xu,li song,zhang minzhou 　　( the second affiliated hospital, guangzhou university of tcm, guangzhou 510120 guangdong, china; hengli peoples hospital of dongguan city, dongguan 523460 guangdong, china) 　　abstract: objectiveto observe the effect of tongmai capsules (tc) on highsensitivity creactive protein (hscrp) in acute coronary syndrome (acs) patients. methodsfiftyfour acs patients ized into the treatment group (n=26) and the control group (n=28). the tent for coronary heart disease and the plications. additionally, the control group ent group ent lasting one month. the change of the symptom scores ent, and the hscrp level at the admission day, on the 7th day of treatment and after treatment for one month ptoms of acs proved to various degrees in both groups (plt;005 or plt;001 pared ent). tc had a better effect on reducing attack frequency, persistence time and the degrees of distress and pain in the chest, and on relieving shortness of breath, lassitude and palpitation(plt;005 or plt;001 pared ent group (plt;005) on the 7th day of treatment and after treatment for one month as pared ission day. in the treatment group, hscrp level ent for one month (plt;005 pared ent). on the 7th day of treatment and after treatment for one month, the hscrp level i